ANTHRACYCLINE CARDIOTOXICITY: THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DEXRAZOXANE AND ITS OPEN RING METABOLITE

被引：0
|
作者：
Jirkovska-Vavrova, A. [1 ]
Jirkovsky, E. [2 ]
Stariat, J. [1 ]
Jansova, H. [1 ]
Roh, J. [1 ]
Lencova-Popelova, O. [2 ]
Kovarikova, P. [1 ]
Sterba, M. [2 ]
Simunek, T. [1 ]
机构：
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic
[2] Charles Univ Prague, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic
来源：
HEART | 2014年 / 100卷
关键词：
D O I：
10.1136/heartjnl-2014-306916.20
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
020
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart
    Jirkovsky, Eduard
    Jirkovska, Anna
    Bures, Jan
    Chladek, Jaroslav
    Lencova, Olga
    Stariat, Jan
    Pokorna, Zuzana
    Karabanovich, Galina
    Roh, Jaroslav
    Brazdova, Petra
    Simunek, Tomas
    Kovarikova, Petra
    Sterba, Martin
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 364 (03): : 433 - 446
  • [32] THE CARDIAC PROTECTIVE EFFECTS OF DEXRAZOXANE ON ANIMAL MODEL OF CARDIOTOXICITY INDUCED BY COMBINATORIAL TREATMENT OF ANTHRACYCLINE AND TRASTUZUMAB
    Zhang, J.
    Zhang, S.
    Meng, T.
    Zhang, X.
    Hao, X.
    Liu, Y.
    Zhang, M.
    Liu, J.
    Li, C.
    ANNALS OF ONCOLOGY, 2014, 25
  • [33] The cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity
    Kwok, JC
    Richardson, DR
    REDOX REPORT, 2000, 5 (06) : 317 - 324
  • [34] Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism
    B. J. Cusack
    H. Gambliel
    B. Musser
    N. Hadjokas
    S. E. Shadle
    H. Charlier
    R. D. Olson
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 517 - 526
  • [35] Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation
    Jirkovsky, Eduard
    Jirkovska, Anna
    Bavlovic-Piskackova, Hana
    Skalicka, Veronika
    Pokorna, Zuzana
    Karabanovich, Galina
    Kollarova-Brazdova, Petra
    Kubes, Jan
    Lencova-Popelova, Olga
    Mazurova, Yvona
    Adamcova, Michaela
    Lyon, Alexander R.
    Roh, Jaroslav
    Simunek, Tomas
    Sterbova-Kovarikova, Petra
    Sterba, Martin
    CIRCULATION-HEART FAILURE, 2021, 14 (11) : E008209
  • [36] Dexrazoxane - A review of its use for cardioprotection during anthracycline chemotherapy
    Cvetkokic, RS
    Scott, LJ
    DRUGS, 2005, 65 (07) : 1005 - 1024
  • [37] Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity
    El-Demerdash, Ebtehal
    Ali, Azza A.
    El-Taher, Dalia E. M.
    Hamada, Farid M. A.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (03) : 344 - 352
  • [38] GENETIC RISK FACTORS OF ANTHRACYCLINE CARDIOTOXICITY - RELEVANT POLYMORPHISMS IDENTIFIED IN ENZYMES AND TRANSPORTERS OF ANTHRACYCLINE PHARMACOKINETICS
    Kutszegi, Nora Zsofia
    Semsei, Agnes F.
    Lautner-Csorba, Orsolya
    Hegyi, Marta
    Szabolcs, Judit
    Benyo, Gabor
    Szalai, Csaba
    Kovacs, Gabor T.
    Erdelyi, Daniel Janos
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1101 - 1101
  • [39] Pharmacokinetics and pharmacodynamics of diltiazem and its metabolite O-desacetyl-diltiazem in healthy volunteers
    Dabrowski, R
    Paczkowski, D
    Kunicki, P
    Sadowski, Z
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R452 - R452
  • [40] PHARMACOKINETICS AND PHARMACODYNAMICS OF QUINIDINE AND ITS METABOLITE, QUINIDINE-N-OXIDE, IN BEAGLE DOGS
    RAKHIT, A
    GUENTERT, TW
    HOLFORD, NHG
    VERHOEVEN, J
    RIEGELMAN, S
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1984, 9 (04) : 315 - 324
12345